Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples.
Brogan AP, DeMuro C, Barrett AM, D'Alessio D, Bal V, Hogue SL. Brogan AP, et al. J Manag Care Spec Pharm. 2017 Feb;23(2):125-134. doi: 10.18553/jmcp.2017.23.2.125. J Manag Care Spec Pharm. 2017. PMID: 28125369 Free PMC article.
The abstract for this article was presented as a research poster at the following meetings: Hogue SL, Brogan A P, De Muro C, D'Alessio D, Bal V. ...Poster presented at the ISPOR 20th Annual Meeting; May 16-20, 2015. Philadelphia PA. Hogue SL, Brogan …
The abstract for this article was presented as a research poster at the following meetings: Hogue SL, Brogan A P, De Mu …
Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United States.
Brogan AP, Hogue SL, Vekaria RM, Reynolds I, Coukell A. Brogan AP, et al. J Manag Care Spec Pharm. 2019 Dec;25(12):1319-1327. doi: 10.18553/jmcp.2019.25.12.1319. J Manag Care Spec Pharm. 2019. PMID: 31778613 Free PMC article.
Outcomes-based contracting could have some utility in specific cases where the treatment has a particularly high cost and a clear outcomes measure, but payers indicated that outcomes-based contracts can be difficult to operationalize, and determination of savings wa …
Outcomes-based contracting could have some utility in specific cases where the treatment has a particularly high cost and a cl …
Re-assessing viologens for modern bio-electrocatalysis.
Koomson DA, Nicholson JH, Brogan APS, Aldous L. Koomson DA, et al. Among authors: brogan aps. Chem Sci. 2024 May 16;15(24):9325-9332. doi: 10.1039/d4sc02431a. eCollection 2024 Jun 19. Chem Sci. 2024. PMID: 38903224 Free PMC article.
Thermally Robust Solvent-Free Liquid Polyplexes for Heat-Shock Protection and Long-Term Room Temperature Storage of Therapeutic Nucleic Acids.
Chen Y, Lin X, Liu X, Liu Y, Bui-Le L, Blakney AK, Yeow J, Zhu Y, Stevens MM, Shattock RJ, Chen R, Brogan APS, Hallett JP. Chen Y, et al. Among authors: brogan aps. Biomacromolecules. 2024 May 13;25(5):2965-2972. doi: 10.1021/acs.biomac.4c00117. Epub 2024 Apr 29. Biomacromolecules. 2024. PMID: 38682378 Free PMC article.
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses.
Benson P, Kuretski J, Donovan C, Harper G, Merrill D, Metzner AA, Mycock K, Wallis H, Brogan AP, Patarroyo J, Oglesby A. Benson P, et al. Among authors: brogan ap. Infect Dis Ther. 2024 Apr;13(4):875-889. doi: 10.1007/s40121-024-00950-1. Epub 2024 Apr 3. Infect Dis Ther. 2024. PMID: 38570444 Free PMC article.
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study.
Schneider S, Blick G, Burke C, Ward D, Benson P, Felizarta F, Green D, Donovan C, Harper G, Merrill D, Metzner AA, Mycock K, Wallis H, Patarroyo J, Brogan AP, Oglesby A. Schneider S, et al. Among authors: brogan ap. Infect Dis Ther. 2024 Apr;13(4):891-906. doi: 10.1007/s40121-024-00961-y. Epub 2024 Apr 3. Infect Dis Ther. 2024. PMID: 38570443 Free PMC article.
82 results